NasdaqGS:ALMSPharmaceuticals
How Alumis’ Revenue Slide but Smaller Per-Share Loss Will Impact Alumis (ALMS) Investors
Alumis Inc. recently reported its first-quarter 2026 results, with revenue of US$1.74 million compared with US$17.39 million a year earlier and a net loss of US$93.05 million versus US$98.96 million.
Despite the sharp revenue drop, the company narrowed its basic loss per share from continuing operations to US$0.74, down from US$1.82, highlighting shifting cost and earnings dynamics.
Next, we’ll examine how Alumis’s sharply lower revenue but reduced loss per share shapes the company’s broader...